| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.75B | 97.07B | 92.19B | 58.35B | 46.06B | 43.77B |
| Gross Profit | 22.31B | 19.14B | 15.88B | 8.90B | 7.84B | 8.40B |
| EBITDA | 12.75B | 10.86B | 8.14B | 3.57B | 3.67B | 4.18B |
| Net Income | 6.12B | 5.57B | 5.52B | 1.06B | 1.72B | 1.13B |
Balance Sheet | ||||||
| Total Assets | 104.24B | 110.35B | 95.92B | 93.57B | 61.13B | 61.32B |
| Cash, Cash Equivalents and Short-Term Investments | 11.37B | 15.45B | 12.51B | 11.26B | 7.65B | 8.52B |
| Total Debt | 13.87B | 17.76B | 10.52B | 12.61B | 5.15B | 5.15B |
| Total Liabilities | 27.78B | 35.99B | 24.81B | 25.30B | 12.22B | 12.77B |
| Stockholders Equity | 76.46B | 72.89B | 71.11B | 68.26B | 48.90B | 48.54B |
Cash Flow | ||||||
| Free Cash Flow | 5.88B | 6.07B | 4.87B | -2.21B | 1.42B | 2.70B |
| Operating Cash Flow | 10.03B | 8.93B | 6.66B | -1.63B | 2.18B | 3.32B |
| Investing Cash Flow | -11.77B | -8.98B | -822.00M | 4.61B | -651.00M | -482.00M |
| Financing Cash Flow | 1.01B | 2.99B | -4.59B | -3.68B | -2.40B | -2.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.48B | 5.17 | ― | 1.91% | 2.73% | 59.02% | |
75 Outperform | ¥93.44B | 9.69 | ― | 3.90% | 11.70% | -3.61% | |
71 Outperform | ¥32.52B | 7.15 | ― | 2.84% | 6.64% | 10.48% | |
69 Neutral | ¥163.54B | 9.61 | ― | 1.39% | 3.91% | -0.28% | |
68 Neutral | ¥111.93B | 10.22 | ― | 3.97% | 3.69% | -27.70% | |
65 Neutral | ¥49.87B | -19.07 | ― | 2.12% | 3.82% | -131.02% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |